The Economic Burden of Bleeds and Transfusions in Selected Surgeries: A Retrospective Multi Center Analysis from the Us Perspective

Abstract

Bleeding is a complication of surgery that may lead to substantial morbidity and mortality. In different type of surgeries (CV, Vascular, Thoracic, Neuro/Neuro-Spine), severe bleeding occurs in approximately 7% of cases [1] and is associated with an increased risk of post-operative mortality [2]. The burden of bleeding in the United States is costly for patients and for the healthcare system. Patients with uncontrolled intraoperative bleeding can be four times more likely to die from a surgical procedure [3]. These patients receive more blood transfusions, have longer hospital stays and have statistically worse outcomes, including significantly higher morbidity rates. The American Medical Association and the Joint Commission have identified blood transfusions as one of the top five over-utilized therapeutic procedures in the U.S. [4]. Efficient surgeries with limited bleeding may be one potential solution. Notable National Health Organizations have begun to address the issue of how to ensure more efficient utilization of blood transfusions.